scholarly journals Atopic dermatitis and risk of atrial fibrillation or flutter: A 35-year follow-up study

2020 ◽  
Vol 83 (6) ◽  
pp. 1616-1624 ◽  
Author(s):  
Sigrun A.J. Schmidt ◽  
Morten Olsen ◽  
Morten Schmidt ◽  
Christian Vestergaard ◽  
Sinéad M. Langan ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Atopic Dermatitis ◽  
Follow Up Study

Risk scoring by CHADS2 and CHA2DS2-VASc as predictors for long-term outcomes after surgical ablation for atrial fibrillation

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
D Lauritzen ◽  
H.J Vodstrup ◽  
T.D Christensen ◽  
M Onat ◽  
R Christensen ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Cardiac Surgery ◽  
Isolation Procedure ◽  
Survival Times ◽  
Long Term Outcomes ◽  
Surgical Ablation ◽  
Follow Up Study ◽  
Risk Scoring

Abstract Background Following catheter ablation for atrial fibrillation (AF), CHADS2 and CHA2DS2-VASc have utility in predicting long-term outcomes. However, it is currently unknown if the same holds for patients undergoing surgical ablation. Purpose To determine whether CHADS2 and CHA2DS2-VASc predict long-term outcomes after surgical ablation in concomitance with other cardiac surgery. Methods In this prospective, follow-up study, we included patients who underwent biatrial ablation - or pulmonary vein isolation procedure concomitantly with other cardiac surgery between 2004 and 2018. CHADS2 and CHA2DS2-VASc scores were assessed prior to surgery and categorized in groups as 0–1, 2–4 or ≥5. Outcomes were death, AF, and AF-related death. Follow-up was ended in April 2019. Results A total of 587 patients with a mean age of 68.7±0.4 years were included. Both CHADS2 and CHA2DS2-VASc scores were predictors of survival p=0.005 and p<0.001, respectively (Figure). For CHADS2, mean survival times were 5.9±3.7 years for scores 0–1, 5.0±3.0 years for scores 2–4 and 4.3±2.6 years for scores ≥5. For CHA2DS2-VASc mean survival times were 7.3±4.0 years for scores 0–1, 5.6±2.9 years for scores 2–4 and 4.8±2.1 years for scores ≥5. The incidence of death was 20.1% for CHADS2 0–1, 24.8% for CHADS2 2–4, and 35.3% for CHADS2 ≥5, p=0.186. The incidence of AF was 50.2% for CHADS2 0–1, 47.9% for CHADS2 2–4, and 76.5% for CHADS2 ≥5, p=0.073. The incidence of AF related death was 13.0% for CHADS2 0–1, 16.8% for CHADS2 2–4, and 35.3% for CHADS2 ≥5, p=0.031. The incidence of death was 16.8% for CHA2DS2-VASc 0–1, 26.2% for CHA2DS2-VASc 2–4, and 45.0% for CHA2DS2-VASc ≥5, p=0.001. The incidence of AF was 49.6% for CHA2DS2-VASc 0–1, 52.5% for CHA2DS2-VASc 2–4, and 72.5% for CHA2DS2-VASc ≥5, p=0.035. The incidence of AF related death was 12.2% for CHA2DS2-VASc 0–1, 16.0% for CHA2DS2-VASc 2–4, and 42.5% for CHA2DS2-VASc ≥5, p<0.001. Conclusion Both CHADS2 and CHA2DS2-VASc scores predict long-term outcomes after surgical ablation for AF. However, CHA2DS2-VASc was superior in predicting death, AF, and AF-related death. Survival curves Funding Acknowledgement Type of funding source: None

scholarly journals Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study

EP Europace ◽  
2008 ◽  
Vol 10 (5) ◽  
pp. 618-623 ◽  
Author(s):  
Lluis Molina ◽  
Lluis Mont ◽  
Jaume Marrugat ◽  
Antonio Berruezo ◽  
Josep Brugada ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Lone Atrial Fibrillation ◽  
Endurance Sport ◽  
Follow Up Study ◽  
Sport Practice

scholarly journals Left Atrial Dispersion Predicts Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy: A 5-year Follow-up study

2020 ◽  
Author(s):  
OZKAN CANDAN ◽  
Ender Cakmak ◽  
CETIN GECMEN ◽  
Muzaffer Kahyaoglu ◽  
Zeki im ek ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Hypertrophic Cardiomyopathy ◽  
Left Atrial ◽  
Follow Up Study

scholarly journals THE EFFECT OF BETA-BLOCKERS ON A COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH A LOW TRIIODOTHYRONINE SYNDROME

2020 ◽  
Vol 73 (7) ◽  
pp. 1402-1409
Author(s):  
Sergiy M. Pyvovar ◽  
Iurii S. Rudyk ◽  
Mykola P. Kopytsya ◽  
Tetiana V. Lozyk ◽  
Valentina Ir. Galchinskaya ◽  
...  
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Opposite Effect ◽  
Beta Blockers ◽  
Thyroid Stimulating Hormone ◽  
Functional Class ◽  
Left Heart ◽  
Follow Up Study ◽  
Serum T3

The aim: The aim is to study the effect of β-ABs in patients with LT3S on the course of HF. Materials and methods: 354 patients with HF on a background of post-infarction cardiosclerosis were included in the 2-yeared follow-up study. LT3S was diagnosed at 89 (25.1%) patients. The levels of thyroid-stimulating hormone, free T3f and T4f, and reversible T3 were determined. The echocardioscopy was performed. Results: Patients with HF in combination with LT3S have a heavier functional class by NYHA, greater dilatation of the left heart cavities, less myocardial contractility, a higher frequency of atrial fibrillation and re-hospitalization. The use of β-ABs in patients with HF without LT3S leads to a likely decrease in hospitalization frequency, while in patients with LT3S it has an opposite effect. The frequency of rehospitalization increases with an excess of β-ABs dose > 5 mg (equivalent to bisoprolol). At these patients a decrease in serum T3 level and negative dynamics of parameters of intracardiac hemodynamics are observed. Conclusions: The use of β-ABs in patients with LT3S leads to an increase in re-hospitalization at a dose over 5.0 mg (equivalent to bisoprolol). In these patients there is a decrease in serum T3, an increase in T4 level; and the ejection fraction decrease; and heart cavities size increase.

scholarly journals 21 Impact of Combined Atrial Fibrillation and Heart Failure on Mortality: 14 Year Naturalistic Follow-Up Study

Heart ◽  
2016 ◽  
Vol 102 (Suppl 6) ◽  
pp. A13-A14
Author(s):  
Oliver Ziff ◽  
Paul R Carter ◽  
John McGowan ◽  
Suresh Chandran ◽  
Hardeep Uppal ◽  
...  
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Follow Up Study
Sign in / Sign up

Export Citation Format

Share Document